Bpifrance SA - Q3 2022 holdings

$2.58 Billion is the total value of Bpifrance SA's 6 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 33.3% .

 Value Shares↓ Weighting
STLA  STELLANTIS NV$2,306,019,000
-2.2%
192,703,9070.0%89.24%
+1.3%
CSTM  CONSTELLIUM NVcl a$166,234,000
-23.2%
16,393,9030.0%6.43%
-20.5%
CRTO  CRITEO S Aspons ads$73,488,000
+10.8%
2,718,7520.0%2.84%
+14.8%
VECT  VECTIVBIO HOLDING AG$16,837,000
+11.1%
2,806,2170.0%0.65%
+15.2%
SQNS  SEQUANSCOMMUNICATIONS S Aspons ads$11,781,000
+32.7%
3,300,0180.0%0.46%
+37.3%
 MIRION TECHNOLOGIES INC$9,610,000
+29.7%
1,286,4460.0%0.37%
+34.3%
RPTX ExitREPARE THERAPEUTICS INC$0-8,055
-100.0%
-0.00%
CLLS ExitCELLECTISspons ads$0-425,726
-100.0%
-0.04%
VCYT ExitVERACYTE INTERNATIONAL$0-152,261
-100.0%
-0.11%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings